Demant A/S Unsponsored ADR (OTCMKTS:WILYY - Get Free Report)'s stock price gapped up prior to trading on Tuesday . The stock had previously closed at $13.45, but opened at $16.30. Demant A/S shares last traded at $16.30, with a volume of 419 shares changing hands.
Analyst Upgrades and Downgrades
Separately, Jefferies Financial Group raised shares of Demant A/S from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, March 18th. Two research analysts have rated the stock with a Strong Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Buy".
Read Our Latest Analysis on Demant A/S
Demant A/S Price Performance
The company has a debt-to-equity ratio of 1.65, a current ratio of 1.36 and a quick ratio of 1.00. The company's 50-day simple moving average is $14.17 and its 200-day simple moving average is $16.15.
Demant A/S Company Profile
(
Get Free Report)
Demant A/S is a Denmark-based global hearing health care company specializing in the development, manufacture and distribution of hearing solutions and audiological diagnostic instruments. The company's flagship brands include Oticon, Bernafon and Sonic, which offer a range of hearing aids designed to address various levels of hearing loss. In addition to personal hearing devices, Demant provides diagnostic equipment such as audiometers and tympanometers, supporting hearing care professionals in accurate assessment and fitting of hearing solutions.
Beyond hearing aids and diagnostics, Demant's product portfolio extends to hearing implants—cochlear and bone-anchored systems—through its Oticon Medical division.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Demant A/S, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Demant A/S wasn't on the list.
While Demant A/S currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
